This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and palliative and end of life care.
This page has been put together rapidly in relation to the COVID-19 pandemic.
Whilst we have tried to ensure that the information on this page is complete, please report a concern if you feel anything is omitted or inaccurate.
To see our professional guidance summaries for other clinical areas, click here
Advice in this area includes:
Last updated 28/4/2020
This medicines re-use SOP for care homes and hospices is a time-limited SOP and would apply only during this period of emergency. The SOP –
- Provides criteria for assessing medicines against and the conditions in which this might be acceptable.
- Applies to medicines that have been supplied to patients while in a care home or hospice, have not been removed from that setting (other than for short periods of up to 24 hours) and have been stored in accordance with good practice guidance on storing medicines in a managed setting.
- Applies to all medicines including liquid medicines, injections (analgesics, insulin), creams and inhalers that are in sealed or blister packs, when appropriate criteria are met.
NHS England/NHS Improvement: Clinical guide for the management of palliative care in hospital during the coronavirus pandemic
Last updated 22/4/2020 Version 2
- Symptom management – short summary [p3]
- Symptom management – pharmacological and non-pharmacological approaches appendix 1 covering breathlessness [p6], cough [p7], delirium [p8] and fever [p9]
Published 24/4/2020 ***note the guide is being updated to reflect changes in case definition for COVID-19 from 18th May 2020 and will be republished soon***
- Symptom management – pharmacological and non-pharmacological approaches appendix 1 covering fever [p3], delirium [p5], cough [p6] and breathlessness [p7]
NICE guideline [NG163]: COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community.
Last updated 30/4/2020
This guideline covers a number of areas including
- Managing symptoms (including cough, fever, breathlessness, anxiety, delirium and agitation) [sections 3-7]
- Managing medicines for patients with COVID-19 [section 8]
- Prescribing anticipatory medicines for patients with COVID-19 [section 9]
The guideline links to other relevant NICE guidelines.
Royal Pharmaceutical Society Emergency Supply of Controlled drugs: supply during a pandemic
- The RPS summarises the legislative changes that have been made around controlled drugs and the situations in which those changes might be enacted
- The changes introduce emergency measures which allow registered pharmacies to supply Schedule 2, 3 or Schedule 4 part 1 CDs without a prescription where the individual has been receiving them as part of on-going treatment and where regular access to a regular repeat prescription is not possible
- These changes, whilst enabled, will only be actioned if and when the Secretary of State switches on the measure
Royal Pharmaceutical Society Changing the intervals of instalments for controlled drugs during a pandemic
- The RPS summarises the changes to controlled drug legislation which allow pharmacists to change the intervals of instalments without a new prescription following agreement with the prescriber or their appointed representative
- These are contingency changes which can only be activated by an announcement by the Secretary of State
- This document describes circumstances where a pharmacist might vary instalment timings and amount if these changes are activated
Association for Palliative Medicine of Great Britain and Ireland: Guidance on Covid-19 and palliative EOL and bereavement care in secondary care
The APM website provides links to:
- the Northern Care Alliance COVID-19 and Palliative, End of Life and Bereavement care in secondary care (V4 20th April 2020) [front page of website]
- a list of COVID-19 resources for healthcare professionals
- the list of priority medicines for palliative and end of life care during a pandemic https://apmonline.org/wp-content/uploads/2020/04/priority-meds-for-end-of-life-care-290420-final-2.pdf
Added 28th May 2020 British Geriatrics Society End of Life Care in Frailty
The aim of this guidance is to support clinicians and others in considering the needs of and providing high quality care for frail older people as they move towards the end of their lives. The BGS guidance is divided into 24 chapters including –
- End of life care in frailty – pain
- End of life care in frailty – medicines management
- End of life care in frailty – dysphagia
- End of life care in frailty – care homes
- End of life care in frailty – community settings
palliativedrugs.com: Collated list of resources for COVID-19 in palliative care
Last updated 12/5/2020 Version 11
This regularly updated, collated list of resources for COVID-19 in palliative care contains links to key resources including:
- COVID-19 and Palliative End of Life and Bereavement care in secondary care (Northern Care Alliance NHS Group and Association for Palliative Medicine) [p1]
- COVID-19 local guidelines [p2]
- useful resources such as guidelines for carer administration of subcutaneous medicines [p2]
Added 28th May 2020 Royal College of General Practitioners and the Association for Palliative Medicine Community Palliative, End of Life and Bereavement Care in the COVID-19 pandemic
Last updated March 2020 Version 3
The link takes you to the RCGP learning page where you’ll find a link to the most recent version of this guidance. This guidance covers topics including –
- Symptom control related to infection with COVID-19
- Flowcharts to assist with fever, pain, cough, breathlessness, delirium
- Holistic care – psychosocial, spiritual, religious and cultural beliefs of patients and families
Added 28th May 2020 The Palliative Care Formulary
- The Palliative Care formulary is accessible on Medicines Complete through a free Open Athens account. Instructions for how to register for this and access the PCF can be found here.